Kisunla Injection, Solution
Product Images NDC 0002-9401

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Kisunla (NDC 0002-9401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label – Kisunla 350 mg Vial (Kisunla 350mg Carton 048 00)

Kisunla 350 mg/20 mL (17.5 mg/mL) injection vial label for donanemab-azbt, an intravenous solution by Eli Lilly and Company. The label includes storage instructions to refrigerate at 2°C to 8°C or room temperature up to 3 days, dosage reference, ingredient list, and barcode. The product is marked Rx only for intravenous infusion and must be diluted before use.*

FDA Label Image

Figure 1 (Kisunla Uspi F1 V1)

A line graph comparing the least squares mean change in amyloid levels (expressed as SUVR on the left y-axis and Centiloids on the right y-axis) over 76 weeks between Kisunla (donanemab-azbt) and placebo. Kisunla shows a marked decrease in amyloid from baseline to week 76, while placebo remains near zero. Participant numbers at different time points are shown below the x-axis.*

FDA Label Image

Figure 2 (Kisunla Uspi F2 V1)

A line graph comparing the least squares (LS) mean change in CDR-SB scores over 76 weeks between Kisunla and placebo groups. The x-axis shows weeks from 0 to 76, and the y-axis shows LS mean change with standard error. Kisunla shows less decline than placebo. Participant numbers for each group at several time points are listed below the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.